A Spanish start-up is working on the development of a technology based on the analysis of eye movements for the diagnosis in early stages of many neurological and mental disorders. In order to validate it the company is looking for hospitals and medical research centres specialized in neurology disorders, willing to conduct clinical trials under subcontracting agreement.
The Spanish start-up was born in 2014 as a medtech company focused on the development of innovative and disruptive solutions in key areas of health systems. The company has developed a diagnosis platform, based on the analysis of eye movements, that combines the analysis of ocular and oculocephalic movements (OM/OCM) with data obtained from other sources (clinical histories, medical explorations, complementary trials and biomarkers).It will help physicians to improve significantly the quality of medical assessments in early stages for many neurological and mental disorders.
Instrumental eye movement analysis can be useful in clinical setting; this technique provides physicians with accurate measures of the different eye movements (saccades, nystagmus, smooth pursuit, vestibulocular reflex) and related parameters (gain, velocity, accuracy, phase, etc.) that cannot be estimated by a simple clinical examination.
The company has already started cooperation with several hospitals and medical research centres from Spain and other countries for the validation of this technology through clinical trials with patients. Nevertheless, the company is looking to expand its cooperation network with more international partners in order to increase the number of clinical trials conducted
- Type of partner sought: The partner sought must hold experience in clinical trials within the field of neurological and mental disorders.
- Specific area of activity of the partner: - Type of partner sought:
Hospitals and medical research centres
- Specific area of activity of the partner:
Specialization in neurological disorders.
- Task to be performed:
To validate this technology throughout clinical trials performanced on patients.
30/10/2018 - Ocean Energy Europe 2018